HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+23.31%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.39B
AUM Growth
+$2.39B
(+2.6%)
Cap. Flow
-$369M
Cap. Flow
% of AUM
-15.47%
Top 10 Holdings %
Top 10 Hldgs %
46.51%
Holding
67
New
22
Increased
12
Reduced
15
Closed
17
Top Buys
| 1 |
Becton Dickinson
BDX
|
$121M |
| 2 |
Cigna
CI
|
$88.6M |
| 3 |
AbbVie
ABBV
|
$83.8M |
| 4 |
Danaher
DHR
|
$66.6M |
| 5 |
Amgen
AMGN
|
$61.1M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$145M |
| 2 |
Haemonetics
HAE
|
$143M |
| 3 |
Teleflex
TFX
|
$119M |
| 4 |
Labcorp
LH
|
$87.3M |
| 5 |
Charles River Laboratories
CRL
|
$84.4M |
Sector Composition
| 1 | Healthcare | 99.83% |
| 2 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Neurocrine Biosciences
NBIX
$13.5B
| $43.4M | 1.82% |
355,770
-1,191,970
| -77% | -$145M |
|
27
Regeneron Pharmaceuticals
REGN
$59.8B
| $35.3M | 1.48% |
+56,550
| New | +$35.3M |
|
28
BioNTech
BNTX
$24.1B
| $33.6M | 1.41% |
+503,920
| New | +$33.6M |
|
|
ARNA
29
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $30.2M | 1.27% |
480,460
+44,120
| +10% | +$2.78M |
|
30
Humana
HUM
$37.5B
| $27M | 1.13% |
69,550
-134,320
| -66% | -$52.1M |
|
31
Zimmer Biomet
ZBH
$20.8B
| $23.7M | 0.99% |
198,350
-625,870
| -76% | -$74.7M |
|
|
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $22.3M | 0.93% |
401,040
-393,440
| -50% | -$21.9M |
|
33
Pacira BioSciences
PCRX
$1.22B
| $21.3M | 0.89% |
405,040
-482,330
| -54% | -$25.3M |
|
|
34
Charles River Laboratories
CRL
$7.99B
| $17.6M | 0.74% |
100,730
-483,890
| -83% | -$84.4M |
|
35
Adaptive Biotechnologies
ADPT
$1.96B
| $16.7M | 0.7% |
+345,370
| New | +$16.7M |
|
|
BLUE
36
DELISTED
bluebird bio
BLUE
| $15.9M | 0.67% |
260,700
-361,510
| -58% | -$22.1M |
|
37
Align Technology
ALGN
$9.59B
| $13.5M | 0.57% |
+49,290
| New | +$13.5M |
|
38
Merck
MRK
$210B
| $13.3M | 0.56% |
+172,310
| New | +$13.3M |
|
39
Vertex Pharmaceuticals
VRTX
$102B
| $7.44M | 0.31% |
+25,620
| New | +$7.44M |
|
|
SRGA
40
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $6.86M | 0.29% |
2,158,644
| – | – |
|
|
SDC
41
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $5.53M | 0.23% |
+700,000
| New | +$5.53M |
|
|
IMGN
42
DELISTED
Immunogen Inc
IMGN
| $5.52M | 0.23% |
+1,200,000
| New | +$5.52M |
|
43
Arcturus Therapeutics
ARCT
$467M
| $4.4M | 0.18% |
+94,200
| New | +$4.4M |
|
|
BMY.RT
44
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $3.99M | 0.17% |
1,115,000
-3,710,260
| -77% | -$13.3M |
|
45
Legend Biotech
LEGN
$6.64B
| $3.19M | 0.13% |
+75,000
| New | +$3.19M |
|
|
FUSN
46
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $2.62M | 0.11% |
+150,000
| New | +$2.62M |
|
47
Tenet Healthcare
THC
$16.5B
| $2.32M | 0.1% |
+128,239
| New | +$2.32M |
|
|
AKUS
48
DELISTED
Akouos, Inc. Common Stock
AKUS
| $2.25M | 0.09% |
+100,000
| New | +$2.25M |
|
49
Generation Bio
GBIO
$40.3M
| $2.1M | 0.09% |
+100,000
| New | +$2.1M |
|
50
Avidity Biosciences
RNA
$6.12B
| $1.41M | 0.06% |
+50,000
| New | +$1.41M |
|